BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38590826)

  • 1. Relationship between autoimmune thyroid antibodies and anti-nuclear antibodies in general patients.
    Ruan Y; Heng XP; Yang LQ; He WD; Li L; Wang ZT; Huang SP; Chen QW; Han Z
    Front Endocrinol (Lausanne); 2024; 15():1368088. PubMed ID: 38590826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
    Yuan S; Yu N; Gao Y; Huang W; He Y; Dong B; Lu G; Li M; Cai X; Peng D; Wang Y; Li T; Huang Y; Gao Y; Guo X; Shi B
    Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):110-4. PubMed ID: 24721350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
    Giovanella L; Ceriani L; Garancini S
    Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSH-receptor autoantibodies in patients with chronic thyroiditis and hypothyroidism.
    Giannone M; Dalla Costa M; Sabbadin C; Garelli S; Salvà M; Masiero S; Plebani M; Faggian D; Gallo N; Presotto F; Bertazza L; Nacamulli D; Censi S; Mian C; Betterle C
    Clin Chem Lab Med; 2022 Jun; 60(7):1020-1030. PubMed ID: 35511904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of GADA, ZnT8A and IA-2A in patients with type 1 diabetes mellitus with thyroid disease and their correlation with thyroid autoantibodies.
    Chen J; Bao C
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):12051-12057. PubMed ID: 38164867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
    Izumi Y; Takeoka K; Amino N
    Endocr J; 2005 Aug; 52(4):493-7. PubMed ID: 16127219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of serum TSH receptor autoantibody concentration and affinity.
    Nakatake N; Sanders J; Richards T; Burne P; Barrett C; Pra CD; Presotto F; Betterle C; Furmaniak J; Smith BR
    Thyroid; 2006 Nov; 16(11):1077-84. PubMed ID: 17123333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy.
    Choi YM; Kwak MK; Hong SM; Hong EG
    Endocrinol Metab (Seoul); 2019 Sep; 34(3):268-274. PubMed ID: 31565879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.
    Liu T; Zhang X; Long L; Zhou L; Chen J; Li M; Gao Y; Zhou X; Han X; Ji L
    BMC Endocr Disord; 2022 Aug; 22(1):218. PubMed ID: 36045442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay.
    Meller J; Jauho A; Hüfner M; Gratz S; Becker W
    Thyroid; 2000 Dec; 10(12):1073-9. PubMed ID: 11201852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus reactivation in peripheral B lymphocytes induces IgM-type thyrotropin receptor autoantibody production in patients with Graves' disease.
    Nagata K; Hayashi K; Kumata K; Satoh Y; Osaki M; Nakayama Y; Kuwamoto S; Ichihara Y; Okura T; Matsuzawa K; Miake J; Fukata S; Imamura T
    Endocr J; 2023 Jun; 70(6):619-627. PubMed ID: 36908137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays.
    Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel third-generation TSH receptor antibody (TRAb) enzyme-linked immunosorbent assay based on a murine monoclonal TSH receptor-binding antibody.
    Roggenbuck JJ; Veiczi M; Conrad K; Schierack P; Wunderlich G; Kotzerke J; Roggenbuck D; Zöphel K
    Immunol Res; 2018 Dec; 66(6):768-776. PubMed ID: 30684216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSH RECEPTOR ANTIBODIES: RELEVANCE & UTILITY.
    Kahaly GJ; Diana T; Olivo PD
    Endocr Pract; 2020 Jan; 26(1):97-106. PubMed ID: 32022598
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
    Tamaki H; Amino N; Iwatani Y; Tachi J; Kimura M; Mitsuda N; Ichihara K; Tanizawa O; Miyai K
    Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays.
    Zöphel K; Roggenbuck D; von Landenberg P; Wunderlich G; Grüning T; Kotzerke J; Lackner KJ; Rees Smith B
    Horm Metab Res; 2010 Jan; 42(1):65-9. PubMed ID: 19830651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in TSH receptor binding and thyroid-stimulating properties between TSH and Graves' IgG. Slowly-acting TSH receptor antibody moieties in Graves' sera affect assay data.
    Saiki Y; Ishihara T; Ikekubo K; Mori T
    Endocr J; 2005 Feb; 52(1):45-55. PubMed ID: 15758557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.